BioProcess Innovation Center - part II
| Reference number | |
| Coordinator | Stuns Stift F Samv Mel Univ i U-A Näringsl & S - STUNS Stiftelsen för samverkan mellan universiteten i Uppsala, näringsliv och samhälle |
| Funding from Vinnova | SEK 1 760 021 |
| Project duration | January 2020 - June 2021 |
| Status | Completed |
| Venture | 2017-01599-en |
Important results from the project
Testa Center, is part of the Swedish government´s commitment to a strong Swedish life science sector. Testa Center is a crucial and a missing link - a complementary infrastructure and verification environment in the development of new biopharmaceuticals. In this project, innovation processes for participating projects have been developed by running 5 verification projects. The model developed, using verification funding to lower the threshold for usage, has been very successful, and the occupancy have been good despite of the pandemic.
Expected long term effects
Testa Center shortens and simplifies the path from research results to product launch. This means that more SMEs are given the opportunity to grow and become more attractive for further investments. By Testa Center, we get a more efficient use of skills and resources, and a more efficient national life science ecosystem. Sweden is given a world-unique competence hub for bioprocesses and bioproduction methods, contributing to making Life Science in Sweden internationally competitive.
Approach and implementation
The project plan, including participating parties and anchoring among stakeholder, has worked very well. It has been very beneficial to have an external, independent party responsible for the development of processes and management of the projects coming through Testa Center. Regarding type application, it has predominantly been biological projects during the 2020, but through the work with Testa Challenge digital and technical projects are also reached. An important conclusion is that verification funding has been a success factor for the start-up of Testa Center.